4/30/2013

Forma Therapeutics and Celgene will collaborate in the discovery, development and commercialization of drug candidates that can regulate protein homeostasis targets. Forma will get an upfront payment and as much as $200 million in research funding. In exchange, Celgene will get the rights to develop and market several drug candidates outside the U.S. Forma will keep the U.S. rights to the drugs arising from the collaboration.

Related Summaries